Mechanisms behind the strong associations of esophageal adenocarcinoma risk with gastroesophageal reflux (GOR) and body mass remain to be defined. In a nationwide population-based case-control study, we examined associations of polymorphisms in the DNA repair genes XPD, XPC, XRCC1 and XRCC3 with risk of esophageal adenocarcinoma, squamous-cell carcinoma (SCC) and gastric cardia adenocarcinoma, and paid special attention to possible interactions with symptomatic reflux or body mass. We collected blood samples from 96, 81 and 126 interviewed incident cases of esophageal adenocarcinoma, esophageal SCC and gastric cardia adenocarcinoma, respectively, and 472 randomly selected controls, frequency-matched with regard to age and sex. DNA was extracted and polymorphisms in XPD codon 751 (Lys!Gln), codon 312 (Asp!Asn), C insertion in intron 10 of XPD, XPC codon 939 (Lys!Gln), XRCC1 codon 399 (Arg!Gln) and XRCC3 codon 241 (Thr!Met) were examined using PCR-RFLP. Odds ratios (ORs) derived from multivariate logistic regression with adjustments for potential confounding factors estimated relative risks. XPD codon 751 Lys/Gln and Gln/Gln genotypes, compared with Lys/Lys genotype, were both associated with a more than doubled risk for esophageal adenocarcinoma (OR ¼ 2.4; 95% CI ¼ 1.4-4.4; OR ¼ 2.7, 95% CI ¼ 1.3-5.9). The combined effects of these genotypes and symptomatic GOR or body mass showed borderline significant deviation from additivity. Excess risks for esophageal SCC were also noted for XPD 751Gln variant genotypes. Other studied variants were not found to be related to the three tumors. Our study suggests that XPD 751Gln allele is a potential genetic marker for susceptibility to esophageal adenocarcinoma.
Introduction
The incidence of esophageal adenocarcinoma has increased rapidly during the past 30 years in Western countries (1) , including Sweden (2) . Gastroesophageal reflux (GOR) (3, 4) , high body mass (5, 6) , low intake of fruits and vegetables (7) and smoking (8, 9) have been identified as risk factors. The mechanisms behind the carcinogenicity of reflux and body mass remain conjectural. Effect modification of the exposurecancer relationship by functional polymorphisms in known carcinogenic or anticarcinogenic pathways may provide important clues to the mechanisms.
Endogenous or exogenous carcinogens or mutants may cause DNA damages. However, DNA damage is continuously repaired through activation of different pathways that involve polymorphic enzymes. There are at least four pathways of DNA repair, each coping with different types of DNA damage (10) . Xeroderma pigmentosum complementation group D and C (XPD, XPC) are 2 out of the >20 genes involved in nucleotide excision repair pathway that repair bulky DNA adducts. Several single-nucleotide polymorphisms (SNPs) have been identified in the XPD gene. Among them, polymorphisms at codon 751 (Lys!Gln) and 312 (Asp!Asn) have been found to be common among Caucasians. Experimental data suggest that these polymorphisms may be functional. In one study, the 751Gln allele was associated with elevated levels of bulky DNA adducts (11) , whereas in another study, the 312Asn allele was linked to diminished apoptotic response to UV-induced DNA damage (12) . Either 751Gln or 312Asn, or their combination, was reported to be linked with reduced DNA repair capacity (13) (14) (15) . A novel polymorphism, single base insertion in intron 10 of the XPD gene, has recently been reported and found to be common among Swedish subjects, although its effects remain to be determined (16) . A common SNP was also found in codon 939 of the XPC gene (Lys!Gln) (17) . The base-excision repair pathway removes small lesions like oxidized or reduced bases, and non-bulky adducts. The X-ray repair cross-complementing group 1 (XRCC1) gene product plays an important role in this pathway. Several evidences indicate that a polymorphism of XRCC1 in codon 399 (Arg!Gln) is functional. The 399Gln allele is associated with higher sister chromatoid exchange frequency induced by smoking or tobacco-specific carcinogens (18, 19) , higher levels of DNA adducts (19, 20) and prolonged cell-cycle delay in response to ionizing radiation (21) . Double-strand breaks induced by ionizing radiation or replication errors are handled by a pathway that includes the X-ray repair complementing 3 (XRCC3) gene products. This gene is also polymorphic and the codon 241Met variant has been associated with higher levels of DNA adducts (22) .
We postulated that interactions, if any, between enigmatic exposures such as reflux or body mass and functional polymorphisms in genes involved in specific DNA repair pathways would provide clues as to the nature of the mechanisms involved in the carcinogenicity of these exposures. We therefore investigated the possible associations of polymorphisms in XPD, XPC, XRCC1 and XRCC3 with the risks for esophageal adenocarcinoma, esophageal squamous-cell carcinoma (SCC) and gastric cardia adenocarcinoma, and explored possible interactions with environmental and 'internal' exposures, such as reflux and body mass, in a Swedish nationwide population-based case-control study.
Methods

Design
Parts of the study methods have been described in detail elsewhere (3) . Briefly, the study base encompassed $20 million person-years experienced by the entire native Swedish population <80 years of age during 1995 through 1997. All newly diagnosed patients in the study base with adenocarcinoma of the esophagus or gastric cardia and half of the patients with SCC of the esophagus (born on even-numbered dates) were eligible as cases. Considerable efforts, including establishment of a comprehensive organization with contact persons at all 195 departments of general surgery, thoracic surgery, otorhinolaryngology, oncology and pathology in Sweden, and continuous collaboration with the six regional tumor registries, were made to ensure that every eligible case was identified shortly after diagnosis. All cases were uniformly classified histologically and topographically, and almost all (97%) biopsies and surgical specimens were reviewed by a single pathologist. Endoscopists, surgeons and pathologists gave standardized, detailed descriptions of the location of the tumors. Cancer of the gastric cardia was defined as a tumor with its center within 2 cm proximal, or 3 cm distal, to the gastroesophageal junction. Control subjects were randomly selected from the study base every 6 months using the continuously updated Swedish population register. They were frequency-matched to resemble the age (in 10 years) and sex distribution among the esophageal adenocarcinoma cases. To be eligible, control subjects should be born in Sweden and cancer-free at time of recruitment.
Interview
Patients and control subjects were interviewed face-to-face by specially trained professional interviewers from Statistics Sweden. The questions covered demographic characteristics, living conditions during childhood and adolescence, occurrence of GOR symptoms, anthropometric measures, smoking, alcohol drinking, dietary history, history of medication use and occupational history. To avoid reverse causality, we disregarded GOR symptoms information that had occurred <5 years before the interview. Also, we used tobacco usage information 2 years before interview to determine the user status, and set the reference time point of anthropometric measures and dietary intakes 20 years before interview. The interviewers could not be kept blinded to case-control status but were trained to treat both groups in a strictly equal manner.
Genotyping
Interviewed subjects were asked to donate a venous blood sample. Whole blood samples were stored at À70 C until DNA was extracted. Genomic DNA was isolated using Gentra's Puregene kit (Gentra Systems, Minneapolis, MN).
Genotyping for polymorphisms in XPD Lys751Gln, XPC Lys939Gln, XRCC1 Arg399Gln and XRCC3 Thr241Met were carried out using PCR-RFLP technique. PCR primers for XPD Lys751Gln polymorphism were 5 0 -CCCCTCTC-CCTTTCCTCTGTT-3 0 (forward) and 5 0 -GCTGCCTTCTCC-TGCGATTA-3 0 (reverse); for XPC Lys939Gln, 5 0 -GATG-CAGGAGGTGGACTCTCT-3 0 (forward) and 5 0 -GTAGTGG-GGCAGCAGCAACT-3 0 (reverse); for XRCC1 Arg399Gln, 5 0 -GCCCCTCAGATCACACCTAAC-3 0 (forward) and 5 0 -CATTGCCCAGCACAGGATAA-3 0 (reverse); and for XRCC3 Thr241Met, 5 0 -GCTCGCCTGGTGGTCATC-3 0 (forward) and 5 0 -CTTCCGCATCCTGGCTAAAAA-3 0 (reverse). PCR products were generated by the use of 10 ng genomic DNA in 10 ml reaction volume containing 1· PCR buffer, 2.0 mM MgCl 2 , 0.11 mM each dNTP, 0.3 mM each primer and 0.3 U Platinum Taq DNA polymerase (Invitrogen, Paisley, UK). PCR products were digested with restriction endonucleases (Fermentas Company, Vilaius, Lithuania or New England Biolabs, Herts, UK) that recognized and cut either wild-type or variant sequences (PstI, PvuII, Msp I, Hsp92 II were used for XPD Lys751Gln, XPC Lys939Gln, XRCC1 Arg399Gln and XRCC3 Thr241Met, respectively). PCR products were digested at 37 C for at least 3 h to overnight. The digested PCR products were resolved on 10% polyacrylamide gel (Bio-Rad, Hercules, CA) and stained with ethidium bromide. XPD Asp312Asn and C insertion in intron 10 were genotyped by a combined SSCP method (16) , and the primers used were 5 0 -GGAGACGGACGCCCACCTG-3 0 (forward) and 5 0 -GACGGGGAGGCGGGAAAG-3 0 (reverse). The genotype results were randomly checked and confirmed by direct DNA sequencing of PCR products. All persons involved in the analyses were blinded to case-control status of the subjects.
Statistical analyses
We checked deviation from Hardy-Weinberg equilibrium among cases and controls by a c 2 -test, with one degree of freedom. HaploView (http://www.broad.mit.edu/personal/ jcbarret/haploview/) was used for measures of pairwise linkage disequilibrium (LD) between SNPs within XPD. Haplotype block structure in XPD was also examined. Individual haplotypes within the same block were estimated by using PHASE 2.0 (http://www.stat.washington.edu/stephens/software.html), a Bayesian method to reconstruct the haplotype using Markov chain Monte Carlo techniques (23) . We then modeled the data using unconditional logistic regression to estimate relative risks in the form of odds ratios (ORs) with 95% confidence intervals (CIs). In multivariate modeling, our basic model included the frequency matching variables-age (6 categories) and sex. We considered reflux symptoms (occurring at least once per week), socioeconomic status (reflected by number of years of formal education and categorized into three categories), intake of fruits and vegetables (categorized in three classes), body mass index (BMI) (in quartiles), tobacco smoking status (two years before interview, classified into never smoker, previous smoker and current smoker of any tobacco) and alcohol use (total amount consumed of all types of alcoholic beverages and categorized into four classes) as potential confounding factors.
Gene-environment interaction was estimated by testing departure from risk-ratio multiplicativity or additivity (24) . Departure from risk-ratio multiplicativity is equivalent to effect-measure modification or statistical interaction, while departure from additivity measures biological interaction. Owing to limited sample size, we dichotomized the genetic polymorphism by grouping subjects into carriers and
non-carriers of the variant allele. Similarly, 'internal' and environmental exposures were dichotomized by appropriate grouping. Using the wild-genotype group without environmental exposure as reference, three relative risks (RR) were estimated: RR 11 for variant group with environmental exposure, RR 10 for variant group without environmental exposure, RR 01 for wild-type group with environmental exposure. To test departure from multiplicativity, multiplicative interaction index (MII) was calculated [MII ¼ RR 11 /(RR 10 · RR 01 )]. MII > 1 implies greater than multiplicative effects; MII ¼ 1 implies multiplicative effects; while MII < 1 implies less than multiplicative effects. P-values for MII were derived from a cross-product term of gene and environment exposure introduced into a multiplicative model. We used interaction contrast ratio (ICR) to test departure from additivity (ICR ¼ RR 11 À RR 10 À RR 01 + 1). ICR > 0 implies greater than additive effects; ICR ¼ 0 implies additive effects; while ICR < 0 implies less than additive effects. CIs of ICR were computed according to the method by Hosmer (25) . An ICR can be considered as statistically significant at alpha level 0.05 if its 95% CIs do not include zero. All statistical analyses were performed using SAS 8.2; PROC GENMOD and PROC LOGISTIC were used for logistic regression modeling.
Ethical considerations
The study was approved by all regional ethics committees in Sweden. Individual informed consent was obtained before interview. Informed consent for subsequent genotyping was further sought from all surviving study subjects.
Results
Overall, 189 (88%) of 216 eligible cases of esophageal adenocarcinoma, 167 (73%) of 228 SCC and 262 (84%) of 313 gastric cardia adenocarcinoma were interviewed. Among 1128 randomly selected control subjects, 820 (73%) were also interviewed. The main reasons of non-response among controls in the interview phase were incorrect address information (2%), unwillingness (19%) or physical/mental illnesses (6%). In total, DNA samples were collected from 304 cases and 492 controls who were interviewed. The main reason for non-availability of biological samples from cases was that the clinicians forgot to collect blood samples according to the protocol, while failure to appear at the local health center was the main reason among the control subjects. Only 1 living case and 6 living controls refused to take part in the genotyping, and another 14 living controls could not be traced. They were excluded from the current study. Finally, 96 case patients with esophageal adenocarcinoma, 81 with esophageal SCC, 126 with gastric cardia adenocarcinoma and 472 control subjects were included in the current analysis (Table I) . They constituted $50% of all interviewed case patients, and $60% of all interviewed controls.
The distributions of participants in the present analysis and those who were interviewed but not included in the present analysis by age, place of residence 20 years ago, gender, symptomatic GOR, BMI, smoking, alcohol consumption and intake of fresh vegetables and fruits are listed in Table I . They were similar in most aspects, except that in the subset not included in the present analysis subjects from southern Sweden were overrepresented among cancer cases and current smokers were more common among controls. Multivariably adjusted ORs linked to the interview-derived exposures were similar when using the two datasets; the only exception was more pronounced effects of smoking on risks of the three studied types of cancer in the subset subjected to the present analysis with genotyping data (data not shown).
Among controls, the allele frequency of XPD 751Gln, XPD 312Asn, XPD C-insertion in intron 10, XPC 939Gln, XRCC1 399Gln and XRCC3 241Met was 36.5, 37.3%, 17.7, 37.7, 36.2 and 33.9%, respectively. Except for XRCC1, the genotype distributions did not deviate from Hardy-Weinberg equilibrium. In general, there was little evidence supporting Defined as the lowest tertile of total consumption of fresh vegetables and fruits.
DNA repair gene polymorphism and esophageal cancer any main effects of XPD 312Asn, XPD C-insertion in intron 10, XPC 939Gln, XRCC1 399Gln and XRCC3 241Met polymorphisms on the risk of esophageal adenocarcinoma, esophageal SCC and gastric cardia adenocarcinoma, either combined or stratified into subtypes. However, the XPD 751Gln allele was more common in cancer cases than in controls. Stratified analyses by cancer subtypes revealed that the effects were confined to esophageal cancer. Using wild-type homozygotes as reference, heterogyzotes and homozygotes for XPD 751Gln conferred a >2-fold relative risk for esophageal adenocarcinoma (OR ¼ 2.4, 95% CI ¼ 1.3-4.4; OR ¼ 2.7, 95% CI ¼ 1.3-5.9, respectively). There was also an association with esophageal SCC of almost the same magnitude (OR ¼ 2.0, 95% CI ¼ 1.1-3.9 for heterozygotes; OR ¼ 1.8, 95% CI ¼ 0.7-4.4 for variant homozygotes) (Table II) . Further mutual adjustment by including other genetic polymorphisms into models did not change the results materially (data not shown). Both XPC and XPD genes belong to the nucleotide excision repair pathway. We further checked the combined effects of polymorphisms in these genes. Cancer cases tended to have more variant alleles than controls, especially for esophageal adenocarcinoma. When using those without or with only one variant allele as reference, subjects with three or more had a 2-fold excess risk for esophageal adenocarcinoma (Table III) . We also checked pairwise LD between the three polymorphisms within the XPD gene, and found a strong LD (D 0 ¼ 1.0) between XPD (Asp312Asn) and C insertion in intron 10 of the XPD gene, and a moderate LD (D 0 ¼ 0.6) between XPD (Asp312Asn) and XPD (Lys751Gln). XPD (Asp312Asn) and C insertion in intron 10 of the XPD gene were found to Other variables included in the models were age, sex, socioeconomic status, symptomatic GOR, BMI, tobacco smoking, alcohol intake and intake of fruits and vegetables. b Genotyping in two control subjects was not successful. be in the same haplotype block, and we thus used these two SNPs to infer individual haplotypes (AG/GA/GG). None of the estimated haplotypes were significantly associated with the risk of any of the three cancer types under study (data not shown).
Notwithstanding the relatively small sample size, we also explored combined effects of the XPD 751Gln polymorphism and some environmental exposures (Table IV) . For the three tumors studied, there was little evidence that combined effects of XPD 751Gln polymorphism and symptomatic GOR, BMI, low intake of fresh vegetables and fruits and smoking, respectively, deviated from multiplicativity. However, for esophageal adenocarcinoma, combined effects between XPD 751Gln polymorphism and symptomatic GOR (ICR ¼ 9.7, 95% CI ¼ À1.0, 20.4, P-value ¼ 0.08) or BMI (ICR ¼ 3.9, 95% CI À1.2, 8.9, P-value ¼ 0.14) seemed to depart from additivity.
Discussion
This is, to the best of our knowledge, the first population-based study that has explored the association between DNA repair gene polymorphisms and risk of esophageal adenocarcinoma. Our study results indicate that carriage of the XPD 751Gln allele may predispose an individual to esophageal adenocarcinoma. Homozygote variants had a slightly higher risk than heterozygotes. Although the ICR was statistically nonsignificant, the combined effects of this genetic polymorphism and each of the 'internal' exposures-GOR and obesitytended to be greater than the simple sums; rather, the effects seemed to multiply. Excess risks for esophageal SCC were also noted for XPD 751 Gln variant genotypes. Polymorphisms in XPD codon 312, XPD C-insertion in intron 10, XPC codon 939, XRCC1 codon 399 and XRCC3 codon 241 did not seem to modulate risk for any of the histological types of esophageal cancer or gastric cardia adenocarcinoma.
Strengths of our study include the population-based design, the almost complete case ascertainment, the efforts made to minimize misclassification of tumors among the cases and the high participation rate in the interview phase. Detailed interview data enabled us to control for a range of conceivable confounding factors. The relatively low proportion of cases and controls who donated whole blood may, however, raise concerns about the internal validity of the study. Our results could have been biased if characteristics of the subjects with DNA samples differed from those of subjects without DNA samples, but comprehensive demographic and exposure data obtained at interview with non-participating cases and controls suggest that selection bias is unlikely to have importantly influenced our results. We found obvious deviation from Hardy-Weinberg equilibrium for XRCC1 399, which was also found in another study among Caucasians (26) . Concerns about systematic errors in genotyping and population stratification may be raised. However, our careful quality control and lack of deviation from Hardy-Weinberg equilibrium for the other five polymorphisms studied indicated that such systematic genotyping error is unlikely. Careful check-up of geographical distribution among those with or without blood samples revealed only small difference. Thus, population stratification also appears very unlikely to be the explanation. In future, formal test of population difference may be performed by using randomly selected genetic markers (27) .
Previous molecular epidemiological studies have found that the XPD 751Gln allele is associated with increased risks for head and neck cancer (28) , melanoma skin cancer (29) and lung cancer (30, 31) . However, inconsistent findings were also reported, including absence of any association with lung (32) (33) (34) , and paradoxical inverse associations with esophageal adenocarcinoma (35) and basal cell carcinoma (36) . Previous reports on the association between XPD 312Asn allele and cancer risk are also controversial, including either positive (31, 37) or null results (14, 38) . Reasons for the previous inconsistent findings may include small sample sizes, inappropriate study design and maybe different LD with other SNPs in different populations. There is no previous epidemiological study on the association between XPD C-insertion in intron 10 and cancer risk. Our results indicated a null association between the XPC 939Gln, XRCC1 399Gln, XRCC3 241Met alleles and the risk for any of the three cancer types studied. The XPC 939Gln allele has recently been reported to be associated with an excess risk for bladder cancer (39) , lung cancer (40) and melanoma (41) . However, a negative association has also been noted for lung cancer (42) . As opposed to our findings, the XRCC1 399Gln allele was shown to be associated with esophageal cancer (mostly SCC) risk in one previous study (43) , while other studies failed to confirm this association (44, 45) . Of interest is that in one recent study, XRCC1 399Gln allele was inversely associated with the risk of GOR diseases and Barrett's esophagus, but not esophageal adenocarcinoma (35) . XRCC3 241Met was reportedly associated with an increased risk for melanoma skin cancer (38) , while no association could be demonstrated with esophageal adenocarcinoma (35) and bladder cancer (46) .
The obviously conflicting results from previous molecular epidemiological studies of the association between DNA repair gene polymorphisms and cancer risk warrant cautious interpretation of our results. The study sample size is relatively small; thus chance findings cannot be excluded. Further, we did not have enough power to detect a modest excess risk. Future studies should be based on larger samples, and they should explore in greater detail the combined effects of genes involved in the specific pathway. Further limitations of our study included multiple statistical testing, which increases the risk for Type-I errors, and the potential selection bias as smoking was underrepresented in control subjects who donated blood samples. Although other mechanisms of cancer protection, like apoptosis, may take over and conceal the effects of deficient repair, strong interaction between the effects of an 'internal' or external exposure and effects of defects in a specific DNA repair pathway could potentially provide important clues to the nature of the DNA damage caused by the exposure. For instance, if the suggested interaction of GOR with the XPD 751Gln polymorphism-but not with functional polymorphisms in other DNA repair pathways-will be confirmed in a larger study, it is likely that the carcinogenecity of reflux at some stage involves the formation of bulky adducts. In conclusion, the XPD 751Gln allele may be a risk factor for both major histological types of esophageal cancer particularly for esophageal adenocarcinoma. Further studies are warranted to confirm this finding.
